Acolad
Manchandan Sandhu Joins Acolad to Lead Life Sciences team
-
Industry veteran Sandhu moves from RWS to Acolad to take over the leadership of Acolad’s Life Sciences business unit
-
Sandhu will be accelerating Acolad’s growth in life sciences across Europe, North America and APAC
May 20, 2024 - Acolad, the global content and language services leader, carries on its strategy of reinforcing its position in the life sciences sector as it announces the appointment of industry expert Manchandan (Chan) Kaur Sandhu as head of its Life Sciences unit.
With extensive experience in the life sciences sector, including a tenure of over seven years at RWS where she held several sales leadership and strategic growth roles, Sandhu will be responsible for powering Acolad’s global strategy for the segment. Additionally, she will drive the expansion of the group’s Clinical Center of Excellence, leveraging her deep expertise in Linguistic Validation and Clinical Translation.
“Welcoming Chan into our team is an amazing opportunity to further position Acolad as a true challenger in Life Sciences.” said Arnaud Daix, Executive Vice President for North America at Acolad. “She will be a key asset to our growth strategy, and her leadership and interpersonal skills will be an inspiration to our teams around the world.”
“I am excited to be joining such a visionary organization to lead its talented Life Sciences team, at such a pivotal moment for the industry” added Sandhu, on her new assignment. “As we tackle shifting global situations and complex health challenges, content and language service providers play a crucial role in fostering communication and innovation within the life sciences industry. It is our responsibility to add value through Gen-AI and a forward-thinking technology stack, which I am thrilled to see in play at Acolad. It is a privilege to be part of all this and to embrace Acolad’s vision of a world where every organization communicates effortlessly across languages and cultures.”
Built on a legacy of over 30 years, and leveraging a global footprint spanning 23 countries, Acolad’s expertise in the content and language services space is unparalleled, as is its commitment to servicing the Life Sciences industry with unwavering quality through its dedicated unit – Acolad Life Sciences.
Specializing in certified language solutions for pharma, medical devices, medtech and clinical research organizations and supported by a team of expert medical translators and a wide-array of technology-driven language solutions, Acolad Life Sciences partners with clients through every stage of product development - from clinical trials to post-market surveillance.
The recent launch of its Clinical Center of Excellence underscores Acolad’s commitment to delivering culturally accurate translations of patient-facing and clinical trial documents. This initiative ensures precision, cultural sensitivity, and strict compliance with the regulatory standards of health authorities worldwide – a commitment that solidifies Acolad's role as a trusted partner in global healthcare communication.
See this news in our website.
About Acolad
Acolad is the global leader in content and language solutions. Its mission is to support companies in every industry to scale across markets and enable growth through cutting-edge technology and localization expertise. Established in 1993, the group is present in 23 countries across Europe, North America, and Asia, with over 1.800 employees supported by a network of +20.000 linguists around the world.
***
Press Contacts
Cláudia Vidreiro
Corporate Communications Manager 